MoonLake Immunotherapeutics PEG Ratio

MoonLake Immunotherapeutics (MLTX) currently reports a PEG ratio of -27.25. That is below the sector sector average of 6.76. Use the charts on this page to explore MoonLake Immunotherapeutics's PEG ratio history and peer comparisons.

MoonLake Immunotherapeutics's PEG ratio of -27.25 is lower than the its sector sector average of 6.76. That is roughly 503.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates MoonLake Immunotherapeutics's market price to a fundamental measure such as earnings, sales, or book value. At -27.25, MLTX can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -27.25, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 6.76. From there, open related valuation or income-statement pages for MoonLake Immunotherapeutics, and consider following MLTX for alerts when major investors trade the stock.